Back to all studies
RecruitingNCT06385223

A Novel Individualized Connectome-guided Approach for Precision Intermittent Theta Burst Stimulation for Depression

This study is recruiting. It focuses on depression and currently lists participation information in Singapore.

DepressionDeviceOver 21 Years
In plain English

Key information made simple

This study is looking at whether a digital support tool can help people with Depression. Participants take part in a digital support tool and complete follow-up assessments. Taking part may give some people access to a digital support tool, but direct benefit is not guaranteed.

What to expect

Your next step

The official record suggests in-person participation through a clinic, with sites including Institute of Mental Health in Singapore. Participation appears to involve a study treatment together with follow-up visits and routine safety or progress checks. The main fit is usually matching the main diagnosis and being able to understand the study and consent, while common reasons not to take part include active substance or alcohol problems that could affect the results and safety concerns that need urgent care first. The official record does not list a formal phase, which usually means this is focused more on feasibility, delivery, or support than a standard drug-development stage.

Public study data

Key study information

Condition
Depression
Study status
Recruiting
Sponsor / lead affiliation
Institute of Mental Health, Singapore
Location / country
Singapore
Registry
ClinicalTrials.gov
Why this study may matter

Why this study may matter

This study may matter because it adds public evidence around depression. HopeStage presents it as a starting point for understanding the study, checking the official source, and preparing questions with a care team.

Before joining

Questions to ask before joining

Official source

Registry reference

This page links back to the public source record so people can verify details directly with the registry and research team.

If you want the full study description, eligibility criteria, locations, and sponsor information in the original format, this is the place to check before taking the next step.

Open source record
Need help deciding?

Ask HopeStage to review this study with me

This form records your interest so HopeStage can follow up with practical guidance. It is not a medical eligibility decision and it does not guarantee a study spot.

Loading the security check...
Study reference: NCT06385223. We only ask for your email here. HopeStage can help you review the study, but this is not a medical eligibility decision.
In practice

For you

Taking part may give access to a new approach being evaluated.

It requires regular visits and structured follow-up.

Requires travel, with in-person participation in Singapore.

Important

Not medical advice

Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com

Study clarity

Things to check before joining

Sponsor
Institute of Mental Health, Singapore
Sponsor type
Research institute
Main activity
brain stimulation
Intervention
Not available
Time commitment
long follow-up or multiple visits
Study phase
Not available
Enrollment
Not available
Recruitment status
Recruiting
Source
Official registry link
FAQ

Questions about this study

What is A Novel Individualized Connectome-guided Approach for Precision Intermittent Theta Burst Stimulation for Depression?

This study is exploring brain stimulation for people with depression. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed.

Who is behind this study, and what type of sponsor is it?

This study is sponsored by Institute of Mental Health, Singapore. Based on the sponsor name or official registry information, it appears to be a research institute. You should verify the details in the official registry record.

What does participation involve, what phase is it, and what should I ask about safety?

This study may involve brain stimulation, study visits, and assessments. The time commitment is long follow-up or multiple visits. The study phase is not available in HopeStage data. Check the official source record to see whether a phase is listed. Enrollment is not available in HopeStage data. HopeStage cannot say whether a study is safe or right for you. Before joining, ask the research team about possible risks, time commitment, visits, side effects, compensation, safety monitoring, and whether participation may affect your current care.

Where can I verify the study details?

Use the official source record linked on this page to check the full study description, recruitment status, eligibility criteria, locations, sponsor information, phase, enrollment, contact details, and any listed risks or requirements.

A Novel Individualized Connectome-guided Approach. — Depression Clinical Trial | HopeStage